The DAV132 colon-targeted adsorbent does not interfere with plasma concentrations of antibiotics but prevents antibiotic-related dysbiosis: a randomized phase I trial in healthy volunteers.
Saved in:
| Title: | The DAV132 colon-targeted adsorbent does not interfere with plasma concentrations of antibiotics but prevents antibiotic-related dysbiosis: a randomized phase I trial in healthy volunteers. |
|---|---|
| Authors: | Messaoudene M; Axe Cancer, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada., Ferreira S; Da Volterra, Paris, France., Saint-Lu N; Da Volterra, Paris, France., Ponce M; Axe Cancer, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada., Truntzer C; Platform of Transfer in Biological Oncology, Georges François Leclerc Cancer Center-Unicancer, Dijon, France.; UMR INSERM 1231, Dijon, France., Boidot R; Molecular Biology, Georges François Leclerc Cancer Center-Unicancer, Dijon, France., Le Bescop C; Da Volterra, Paris, France., Loppinet T; Da Volterra, Paris, France., Corbel T; Da Volterra, Paris, France., Féger C; Da Volterra, Paris, France.; Medical, EMI Biotech, Paris, France., Bertrand K; Da Volterra, Paris, France., Elkrief A; Axe Cancer, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada.; Hemato-Oncology Division, Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, QC, Canada., Isaksen M; Bio-Me, Oslo, Norway., Vitry F; Da Volterra, Paris, France., Sablier-Gallis F; Da Volterra, Paris, France., Andremont A; Da Volterra, Paris, France., Bod L; Krantz Family Cancer Center, Center for Immunology and Inflammatory Diseases, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Ghiringhelli F; Department of Medical Oncology, Georges François Leclerc Cancer Center-Unicancer, Dijon, France., de Gunzburg J; Da Volterra, Paris, France., Routy B; Axe Cancer, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada. Bertrand.routy@umontreal.ca.; Hemato-Oncology Division, Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, QC, Canada. Bertrand.routy@umontreal.ca. |
| Source: | Nature communications [Nat Commun] 2024 Sep 15; Vol. 15 (1), pp. 8083. Date of Electronic Publication: 2024 Sep 15. |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39278946 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The DAV132 colon-targeted adsorbent does not interfere with plasma concentrations of antibiotics but prevents antibiotic-related dysbiosis: a randomized phase I trial in healthy volunteers. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Messaoudene+M%22">Messaoudene M</searchLink>; Axe Cancer, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Ferreira+S%22">Ferreira S</searchLink>; Da Volterra, Paris, France.<br /><searchLink fieldCode="AU" term="%22Saint-Lu+N%22">Saint-Lu N</searchLink>; Da Volterra, Paris, France.<br /><searchLink fieldCode="AU" term="%22Ponce+M%22">Ponce M</searchLink>; Axe Cancer, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Truntzer+C%22">Truntzer C</searchLink>; Platform of Transfer in Biological Oncology, Georges François Leclerc Cancer Center-Unicancer, Dijon, France.; UMR INSERM 1231, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Boidot+R%22">Boidot R</searchLink>; Molecular Biology, Georges François Leclerc Cancer Center-Unicancer, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Le+Bescop+C%22">Le Bescop C</searchLink>; Da Volterra, Paris, France.<br /><searchLink fieldCode="AU" term="%22Loppinet+T%22">Loppinet T</searchLink>; Da Volterra, Paris, France.<br /><searchLink fieldCode="AU" term="%22Corbel+T%22">Corbel T</searchLink>; Da Volterra, Paris, France.<br /><searchLink fieldCode="AU" term="%22Féger+C%22">Féger C</searchLink>; Da Volterra, Paris, France.; Medical, EMI Biotech, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bertrand+K%22">Bertrand K</searchLink>; Da Volterra, Paris, France.<br /><searchLink fieldCode="AU" term="%22Elkrief+A%22">Elkrief A</searchLink>; Axe Cancer, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada.; Hemato-Oncology Division, Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Isaksen+M%22">Isaksen M</searchLink>; Bio-Me, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Vitry+F%22">Vitry F</searchLink>; Da Volterra, Paris, France.<br /><searchLink fieldCode="AU" term="%22Sablier-Gallis+F%22">Sablier-Gallis F</searchLink>; Da Volterra, Paris, France.<br /><searchLink fieldCode="AU" term="%22Andremont+A%22">Andremont A</searchLink>; Da Volterra, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bod+L%22">Bod L</searchLink>; Krantz Family Cancer Center, Center for Immunology and Inflammatory Diseases, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ghiringhelli+F%22">Ghiringhelli F</searchLink>; Department of Medical Oncology, Georges François Leclerc Cancer Center-Unicancer, Dijon, France.<br /><searchLink fieldCode="AU" term="%22de+Gunzburg+J%22">de Gunzburg J</searchLink>; Da Volterra, Paris, France.<br /><searchLink fieldCode="AU" term="%22Routy+B%22">Routy B</searchLink>; Axe Cancer, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada. Bertrand.routy@umontreal.ca.; Hemato-Oncology Division, Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, QC, Canada. Bertrand.routy@umontreal.ca. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2024 Sep 15; Vol. 15 (1), pp. 8083. <i>Date of Electronic Publication: </i>2024 Sep 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39278946 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-024-52373-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 8083 Titles: – TitleFull: The DAV132 colon-targeted adsorbent does not interfere with plasma concentrations of antibiotics but prevents antibiotic-related dysbiosis: a randomized phase I trial in healthy volunteers. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Messaoudene M – PersonEntity: Name: NameFull: Ferreira S – PersonEntity: Name: NameFull: Saint-Lu N – PersonEntity: Name: NameFull: Ponce M – PersonEntity: Name: NameFull: Truntzer C – PersonEntity: Name: NameFull: Boidot R – PersonEntity: Name: NameFull: Le Bescop C – PersonEntity: Name: NameFull: Loppinet T – PersonEntity: Name: NameFull: Corbel T – PersonEntity: Name: NameFull: Féger C – PersonEntity: Name: NameFull: Bertrand K – PersonEntity: Name: NameFull: Elkrief A – PersonEntity: Name: NameFull: Isaksen M – PersonEntity: Name: NameFull: Vitry F – PersonEntity: Name: NameFull: Sablier-Gallis F – PersonEntity: Name: NameFull: Andremont A – PersonEntity: Name: NameFull: Bod L – PersonEntity: Name: NameFull: Ghiringhelli F – PersonEntity: Name: NameFull: de Gunzburg J – PersonEntity: Name: NameFull: Routy B IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 09 Text: 2024 Sep 15 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 15 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |
